CA Patent

CA3181327A1 — Pharmaceutical compounding methods and systems

Assigned to Medisca Pharmaceutique Inc · Expires 2018-05-17 · 8y expired

What this patent protects

The present disclosure relates to a system and process for manufacturing patient personalized pharmaceutical compositions using superimposed revolution and rotation movements for dispersing, milling, melting, and/ or de-aerating, where these superimposed revolution and rotation m…

USPTO Abstract

The present disclosure relates to a system and process for manufacturing patient personalized pharmaceutical compositions using superimposed revolution and rotation movements for dispersing, milling, melting, and/ or de-aerating, where these superimposed revolution and rotation movements can be carried out in a single device in a pharmacy setting.

Drugs covered by this patent

Patent Metadata

Patent number
CA3181327A1
Jurisdiction
CA
Classification
Expires
2018-05-17
Drug substance claim
No
Drug product claim
No
Assignee
Medisca Pharmaceutique Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.